Age >70 OR ECOG ≥3 OR CrCl 50-70 mL/min — full-dose HD-MTX (≥3.5 g/m²) carries excessive...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-PCNSL-FRAILTY-AGE |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-PCNSL |
| Sources | SRC-ESMO-DLBCL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Age >70 OR ECOG ≥3 OR CrCl 50-70 mL/min — full-dose HD-MTX (≥3.5 g/m²) carries excessive toxicity; reduced-dose MTX (1-3 g/m²) ± rituximab considered. |
|---|---|
| Clinical direction | de-escalate |
| Category | frailty-age |
| Shifts algorithm | ALGO-PCNSL-1L |
Trigger Logic
{
"any_of": [
{
"comparator": ">",
"finding": "age_years",
"threshold": 70
},
{
"comparator": ">=",
"finding": "ecog_status",
"threshold": 3
},
{
"all_of": [
{
"comparator": ">=",
"finding": "creatinine_clearance_ml_min",
"threshold": 50
},
{
"comparator": "<=",
"finding": "creatinine_clearance_ml_min",
"threshold": 70
}
]
}
],
"type": "composite_clinical"
}
Notes
Elderly PCNSL OS dominated by tolerability of induction; reduced-dose MTX with rituximab achieves comparable response rates with markedly less toxicity. Decision sits within Indication-level dose-adjustment, not 1L Algorithm branch.
Used By
Algorithms
ALGO-PCNSL-1L- ALGO-PCNSL-1LALGO-PCNSL-2L- ALGO-PCNSL-2L
Indications
IND-PCNSL-2L-RMPV-SALVAGE- IND-PCNSL-2L-RMPV-SALVAGE